APLM
Price
$26.93
Change
-$3.17 (-10.53%)
Updated
Oct 21 closing price
Capitalization
57.72M
Intraday Buy/Sell Signals
HRGN
Price
$1.85
Change
+$0.02 (+1.09%)
Updated
Oct 20 closing price
Capitalization
31.78M
19 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

APLM vs HRGN

Header iconAPLM vs HRGN Comparison
Open Charts APLM vs HRGNBanner chart's image
Apollomics
Price$26.93
Change-$3.17 (-10.53%)
Volume$41.43K
Capitalization57.72M
Harvard Apparatus Regenerative Technology
Price$1.85
Change+$0.02 (+1.09%)
Volume$192
Capitalization31.78M
APLM vs HRGN Comparison Chart in %
APLM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HRGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APLM vs. HRGN commentary
Oct 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APLM is a Hold and HRGN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 22, 2025
Stock price -- (APLM: $26.93 vs. HRGN: $1.85)
Brand notoriety: APLM and HRGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APLM: 12% vs. HRGN: 10%
Market capitalization -- APLM: $57.72M vs. HRGN: $31.78M
APLM [@Biotechnology] is valued at $57.72M. HRGN’s [@Biotechnology] market capitalization is $31.78M. The market cap for tickers in the [@Biotechnology] industry ranges from $109.29B to $0. The average market capitalization across the [@Biotechnology] industry is $2.07B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APLM’s FA Score shows that 0 FA rating(s) are green whileHRGN’s FA Score has 0 green FA rating(s).

  • APLM’s FA Score: 0 green, 5 red.
  • HRGN’s FA Score: 0 green, 5 red.
According to our system of comparison, APLM is a better buy in the long-term than HRGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APLM’s TA Score shows that 3 TA indicator(s) are bullish while HRGN’s TA Score has 3 bullish TA indicator(s).

  • APLM’s TA Score: 3 bullish, 3 bearish.
  • HRGN’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, APLM is a better buy in the short-term than HRGN.

Price Growth

APLM (@Biotechnology) experienced а +46.10% price change this week, while HRGN (@Biotechnology) price change was -8.83% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.78%. For the same industry, the average monthly price growth was +16.12%, and the average quarterly price growth was +65.35%.

Reported Earning Dates

HRGN is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Biotechnology (+2.78% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
APLM($57.7M) has a higher market cap than HRGN($31.8M). APLM YTD gains are higher at: 176.205 vs. HRGN (-37.893). HRGN has higher annual earnings (EBITDA): -6.52M vs. APLM (-56.38M). HRGN has less debt than APLM: HRGN (249K) vs APLM (4.72M). HRGN has higher revenues than APLM: HRGN (679K) vs APLM (0).
APLMHRGNAPLM / HRGN
Capitalization57.7M31.8M181%
EBITDA-56.38M-6.52M865%
Gain YTD176.205-37.893-465%
P/E RatioN/AN/A-
Revenue0679K-
Total CashN/A786K-
Total Debt4.72M249K1,897%
FUNDAMENTALS RATINGS
HRGN: Fundamental Ratings
HRGN
OUTLOOK RATING
1..100
88
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
PROFIT vs RISK RATING
1..100
93
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
59
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
APLMHRGN
RSI
ODDS (%)
Bearish Trend 1 day ago
34%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
59%
Bullish Trend 1 day ago
69%
Momentum
ODDS (%)
N/A
Bearish Trend 1 day ago
84%
MACD
ODDS (%)
Bullish Trend 1 day ago
52%
Bearish Trend 1 day ago
79%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
48%
Bearish Trend 1 day ago
78%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
42%
Bearish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 6 days ago
76%
Bullish Trend 14 days ago
66%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 8 days ago
82%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
85%
Aroon
ODDS (%)
Bullish Trend 1 day ago
32%
Bullish Trend 1 day ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
APLM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HRGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AUTR0.710.15
+26.25%
Autris
SFOSF3.30N/A
N/A
Shanghai Fosun Pharmaceutical Group Co Ltd
HRGG17.84N/A
N/A
Heritage Nola Bancorp Inc
KPLIF0.27N/A
N/A
Keppel Infrastructure Trust
NBCDF18.48N/A
N/A
National Bank of Canada

APLM and

Correlation & Price change

A.I.dvisor indicates that over the last year, APLM has been loosely correlated with SNTI. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if APLM jumps, then SNTI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APLM
1D Price
Change %
APLM100%
-10.53%
SNTI - APLM
47%
Loosely correlated
-4.21%
HCWB - APLM
45%
Loosely correlated
-0.25%
MGX - APLM
37%
Loosely correlated
-5.97%
IPHA - APLM
36%
Loosely correlated
-0.94%
QSI - APLM
34%
Loosely correlated
-9.48%
More

HRGN and

Correlation & Price change

A.I.dvisor tells us that HRGN and FTRE have been poorly correlated (+6% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HRGN and FTRE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HRGN
1D Price
Change %
HRGN100%
N/A
FTRE - HRGN
6%
Poorly correlated
-0.29%
APLM - HRGN
3%
Poorly correlated
-10.53%
GENFF - HRGN
2%
Poorly correlated
N/A
ANL - HRGN
2%
Poorly correlated
+0.30%
CLDI - HRGN
2%
Poorly correlated
-5.00%
More